← Back to Patent Explorer
US4663146A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods and compositions for the diagnosis of bloodclots using plasminogen activator

Assignee: Bayer Pharma AG
•
Filing: 1983-07-29
•
Granted: 1987-05-05
•
Expires: 2003-07-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods for detecting fibrin or fibrin clots in a host suspected of producing fibrin by: introducing labeled tissue plasminogen activator or a binding site fragment derived therefrom into the host's bloodstream and assaying for the presence of concentrations of labeled tissue plasminogen activator in said host. Also provided are kits for practicing the invention.

Inventors

  • 👤 Michael J. Morser
  • 👤 Marc A. Shuman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 21:11
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/08; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/86; A61K2123/00; G01N2333/00; G01N2333/435; G01N2333/745; G01N2333/75; G01N2333/90; G01N2333/914; G01N2333/948; G01N2333/972; G01N2333/9726

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 55 words
A method for detecting fibrin or fibrin clots in a host suspected of producing fibrin comprising: introducing a given amount of fibrin binding site fragment of tissue plasminogen activator which is labeled with a detectable indicator into the bloodstream of a host; and assaying for the presence of labeled binding site fragment in said host.
Claim 2
Independent Claim 55 words
A method for detecting fibrin or fibrin clots in a host suspected of producing fibrin comprising: introducing a given amount of fibrin binding site fragment of tissue plasminogen activator which is labeled with a detectable indicator into the bloodstream of a host; and assaying for the presence of labeled binding site fragment in said host.
Claim 3
Dependent Claim 44 words
A method as recited in claim 1 further comprising waiting for the unbound labeled fibrin binding site fragment of tissue plasminogen activator to be cleared from the bloodstream of the host prior to assaying for concentrations of labeled binding site fragment in said host.
Claim 4
Dependent Claim 22 words
A method as recited in claim 1 wherein said fibrin binding site fragment of tissue plasminogen activator is labeled with a radioisotope.
Claim 5
Dependent Claim 22 words
A method as recited in claim 3 wherein that fibrin binding site fragment of tissue plasminogen activator is labeled with 125 I.
Claim 6
Dependent Claim 64 words
A diagnostic kit for the detection and determination of fibrin or fibrin clots in a host suspected of producing fibrin, comprising: a given amount of fibrin binding site fragment of tissue plasminogen activator which is labeled with a detectable indicator; a pharmaceutically acceptable carrier suitable for injection into the blood stream of the host, which labeled fragment and carrier are packaged as a unit.
Claim 7
Dependent Claim 64 words
A diagnostic kit for the detection and determination of fibrin or fibrin clots in a host suspected of producing fibrin, comprising: a given amount of fibrin binding site fragment of tissue plasminogen activator which is labeled with a detectable indicator; a pharmaceutically acceptable carrier suitable for injection into the blood stream of the host, which labeled fragment and carrier are packaged as a unit.
Claim 8
Dependent Claim 24 words
A diagnostic kit as recited in claim 5 wherein said labeled fibrin binding site fragment of tissue plasminogen activator is labeled with a radioisotope.
Claim 9
Dependent Claim 14 words
A diagnostic kit as recited in claim 6 wherein said radioisotope is 125 I.

References Cited (Backward Citations)

US4381346A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-05-04 1990-11-03 1991-05-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-05-04 1994-11-03 1995-05-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-05-04 1998-11-03 1999-05-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag